000			02151pam a2200289 a 4500
001			4491675
003			OSt
005			20230919103724.0
008			971031s1998 nyua b 001 0 eng c
010			_a 97045853
020			_a0824701402 (acidfree paper)
040			_aBUL _cBUL _dBUL _beng _erda
060	1	0	_aWG 300 A1858 1998
245	0	0	_aAcute coronary syndromes / _cedited by Eric J. Topol.
260			_aNew York : _bMarcel Dekker, Inc., _cc1998.
300			_ax, 628 p. : _bill. ; _c24 cm.
504			_aIncludes bibliographical references and index.
505			_aContents 1. Molecular basis; 2. Plaque rupture - pathological-anatomical considerations; 3. Insights from intravascular interrogation; 4. Differences between unstable angina and MI - the pathophysiological and clinical spectrum; 5. Acute ST elevation MI - current approach and the open artery; 6. Prehospital therapy; 7. Thrombolysis for AMI - first and second generation (SK, UK, t-PA, APSAC); 8. Thrombolysis for AMI - third generation (r-PA, n-PA, TNK, STAR, bat-PA); 9. Chest pain centres and emergency room management; 10. Primary PTCA; 11. Myocardial rupture; 12. Antiplatelet therapy; 13. Heparin, hirudin and antithrombin therapy; 14. Bedside anticoagulant testing; 15. Role of troponin and other markers for myocardial necrosis; 16. Angiography and revascularization with attention to regional and international differences; 17. Review of the GUSTO trials (I, II and III); reperfusion injury; 18. Stenting for acute coronary syndromes; 19. Plaque stabilization and secondary prevention; 20. Quality of acute MI care - "scorecards".
650		0	_aCoronary heart disease.
650	1	2	_aMyocardial Infarction _xdiagnosis.
650	1	2	_aMyocardial Infarction _xtherapy.
650	2	2	_aFibrinolytic Agents _xtherapeutic use.
700	1		_aTopol, Eric J., _d1954-
942			_2ddc _cBO _hWG 300 A1858 1998 _i1 _kWG 300 _mA1858 1998
999			_c9135 _d9135